De novo Urothelial carcinoma in kidney transplantation patients with end-stage aristolochic acid nephropathy in China

Urologia Internationalis

Volumn 83, Issue 2, 2009, Pages 200-205

  Yuan, Ming ^a   Shi, Bing Yi ^a   Li, Han Zhong ^b   Xia, Ming ^b   Han, Yong ^a   Xu, Xiao Guang ^a   Zhang, Yin Sheng ^b  

^a Second Affiliated Hospital   (China)

^b PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Aristolochic acid nephropathy; Chinese herb nephropathy; Herbal medicines; Kidney transplantation; Urothelial carcinoma

Indexed keywords

ARISTOLOCHIC ACID; AZATHIOPRINE; CYCLOSPORIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; STEROID; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; AGED; ARTICLE; CANCER RECURRENCE; CHINA; CLINICAL ARTICLE; CLINICAL EVALUATION; COHORT ANALYSIS; CONTROLLED STUDY; END STAGE ARISTOLOCHIC ACID NEPHROPATHY; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HUMAN; KIDNEY DISEASE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; MEDICAL RECORD REVIEW; NEPHROURETERECTOMY; POSTOPERATIVE COMPLICATION; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCREENING; TREATMENT DURATION; URINARY TRACT; UROGENITAL TRACT CANCER; UROTHELIAL CARCINOMA;

ADULT; AGED; ARISTOLOCHIC ACIDS; CARCINOMA, TRANSITIONAL CELL; CHINA; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY NEOPLASMS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES;

EID: 70349292932     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000230024     Document Type: Article

References (13)

1. Vanherweghem JL, Depierreux M, Tielemans C, Abramowicz D, Dratwa M, Jadoul M, Richard C, Vandervelde D, Verbeelen D, Vanhaelen-Fastre R: Rapidly progressive interstitial renal fibrosis in young women: Association with slimming regimen including Chinese herbs. Lancet 1993; 341: 387-391.
2. Chang CH, Wang YM, Yang AH, Chiang SS: Rapidly progressive interstitial renal fibrosis associated with Chinese herbal medications. Am J Nephrol 2001; 21: 441-448.
3. Debelle FD, Vanherweghem JL, Nortier JL: Aristolochic acid nephropathy: A worldwide problem. Kidney Int 2008; 74: 158-169.
4. Cosyns JP, Jadoul M, Squifflet JP, Wese FX, van Ypersele de Strihou C: Urothelial malignancy in nephropathy due to Chinese herbs. Lancet 1994; 344: 188. (Pubitemid 24218887)
5. Cosyns JP, Jadoul M, Squifflet JP, Wese FX, van Ypersele de Strihou C: Urothelial lesions in Chinese-herb nephropathy. Am J Kidney Dis 1999; 33: 1011-1017.
6. Nortier JI, Martinez MC, Schmeiser HH, Arlt VM, Bieler CA, Petein M, Depierreux MF, De Pauw L, Abramowicz D, Vereerstraeten P, Vanherweghem JL: Urothelial carcinoma associated with the use of Chinese herb ( Aristolochia fangchi ). N Engl J Med 2000; 342: 1686-1692.
7. Lord GM, Cook T, Arlt VM, Schmeiser HH, Williams G, Pusey CD: Urothelial malignant disease and Chinese herbal nephropathy. Lancet 2001; 358: 1515-1516.
8. Nortier JL, Schmeiser HH, Martinez MC, Arlt VM, Vervaet C, Garbar CH, Daelemans P, Vanherweghem JL: Invasive urothelial carcinoma after exposure to Chinese herbal medicine containing aristolochic acid may occur without severe renal failure. Nephrol Dial Transplant 2003; 18: 426-428.
9. Li WH, Yang L, Su T, Song Y, Li XM: Influence of taking aristolochic acid-containing Chinese drugs on occurrence of urinary transitional cell cancer in uremic patients undergoing dialysis (in Chinese). Zhonghua Yi Xue Za Zhi 2005; 85: 2487-2491.
10. Stiborová M, Sopko B, Hodek P, Frei E, Schmeiser HH, Hudecek J: The binding of aristolochic acid I to the active site of human cytochromes P450 1A1 and 1A2 explains their potential to reductively activate this human carcinogen. Cancer Lett 2005; 229: 193-204.
11. Arlt VM, Alunni-Perret V, Quatrehomme G, Ohayon P, Albano L, Gaïd H, Michiels JF, Meyrier A, Cassuto E, Wiessler M, Schmeiser HH, Cosyns JP: Aristolochic acid (AA)-DNA adduct as marker of AA exposure and risk factor for AA nephropathy-associated cancer. Int J Cancer 2004; 111: 977-980.
12. Penn I: Malignancies associated with renal transplantation. Urology 1977; 10: 57-63.
13. Sheil AG, Disney AP, Mathew TH, Livingston BE, Keogh AM: Lymphoma incidence, cyclosporine, and the evolution and major impact of malignancy following organ transplantation. Transplant Proc 1997; 29: 825-827.